SpringerLink
Log in

Effect of potassium chloride and cationic drug on swelling, erosion and release from κ-carrageenan matrices

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The basic objective of this work was to study the effect of model cationic drug metformin HCl on swelling and erosion and, in turn, the release of KCl and drug itself, from the κ-carrageenan matrices. Water uptake by the matrix up to 2 hours was found to increase with KCl concentration from the plain matrix. Erosion was not affected by concentration of KCl. Incorporation of drug favors water uptake, but in presence of KCl it was found to be reduced. Drugcontaining matrices have shown higher release of KCl as compared with plain batches. Drug release was retarded as KCl concentration increased up to 5%, above which the reduced cohesivity of the matrix caused increase in drug release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brazel CS, Peppas NA. Modelling of drug release from swellable polymers. Eur J Pharm Biopharm. 2000;49:47–58.

    Article  CAS  Google Scholar 

  2. Guo JH, Skinner GW, Harcum WW, Barnum PE. Pharmaceutical application of naturally occurring water-soluble polymers. PSTT. 1998;1:254–261.

    CAS  Google Scholar 

  3. Gupta VK, Hariharan M, Wheately TA, Price JC. Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors. Eur J Pharm Biopharm. 2001;51:241–248.

    Article  CAS  Google Scholar 

  4. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111.

    CAS  Google Scholar 

  5. FMC: Marine Colloids Carrageenan, General Technology. Philadelphia, PA: FMC Corporation; 1993.

    Google Scholar 

  6. Hariharan M, Wheatley TA, Price JC. Controlled-release tablet matrices from carrageenans: compression and dissolution studies. Pharm Dev Technol. 1997;2:383–393.

    Article  CAS  Google Scholar 

  7. Masaaki S, Chikanori Y, Kazuhiro H, et al. Structural change of κ-carrageenan gel near sol-gel transition point. Physica B. 1998;243:999–1001.

    Article  Google Scholar 

  8. van de Velde F, Peppelman A, Rollema HS, Tromp RH. On the structure of κτ-hybrid carrageenans. Carbohydr Res. 2001;331:271–283.

    Article  Google Scholar 

  9. Yuguchi Y, Thuy TTT, Urakawa H, Kajiwara K. Structural characteristic of carrageenan gels: temperature and concentration dependence. Journal. 2002;16:515–522.

    CAS  Google Scholar 

  10. Picker KM. Carrageenans used for tabletting and controlled release. Proceedings of the 2nd World Meeting. May 25–28, 1998; Paris, France.

  11. Picker KM. Matrix tablets of carrageenans. I. A compaction study. Drug Dev Ind Pharm. 1999;25:329–337.

    Article  CAS  Google Scholar 

  12. Jovetic S, Beeftink HH, Tramper J, Marinelli F. Diffusion of (de)acylated antibiotic A40926 in alginate and carrageenan beads with or without cells and/or soybean meal. Enzyme and Microbiology Technology. 2001;28:510–514.

    Article  Google Scholar 

  13. Sipahigil O, Dortune B. Preparation and in vitro evaluation of verapamil HCl and ibuprofen containing carrageenan beads. Int J Pharm. 2001;228:119–128.

    Article  CAS  Google Scholar 

  14. Hoffinan AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002;54:3–12.

    Article  Google Scholar 

  15. Rochas C, Rinaudo M. Activity coefficient of counterions and conformation in κ-carrageenan system. Biopolymers. 1980;19:1675–1687.

    Article  CAS  Google Scholar 

  16. Morris ER, Rees DA, Norto IT, Goodall DM. Cation-specific aggregation of carrageenan helices: domain model of polymer gel structure. J Mol Biol. 1980;138:349–362.

    Article  CAS  Google Scholar 

  17. Schmidt AG, Wartewigand S, Picker KM. Potential of carrageenan to protect drugs from polymorphic transformation. Eur J Pharm Biopharm. 2003;56:101–110.

    Article  CAS  Google Scholar 

  18. Picker KM. Matrix tablets of Carrageenans. II. Release behavior and effect of added cations. Drug Dev Ind Pharm. 1999;25:339–346.

    Article  CAS  Google Scholar 

  19. Sjöberg H, Persson S, Caram-Lelham N. How interactions between drugs and agarose-carrageenan hydrogels influence the simultaneous transport of drugs. J Control Release. 1999;59:391–400.

    Article  Google Scholar 

  20. Roy DS, Rohera BD. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur J Pharm Sci. 2002;16:193–199.

    Article  Google Scholar 

  21. Vergnaud JM. Liquid transport controlled release process in polymeric materials: applications to oral dosage forms. Int J Pharm. 1993;90:89–94.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Bharati Vidyapeeth Deemed University, Poona College of Pharmacy, Erandwane, 411038, Pune, Maharashtra, India

    Syed Naim, Betty Samuel, Bhaskar Chauhan & Anant Paradkar

Authors
  1. Syed Naim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Betty Samuel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bhaskar Chauhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anant Paradkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anant Paradkar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naim, S., Samuel, B., Chauhan, B. et al. Effect of potassium chloride and cationic drug on swelling, erosion and release from κ-carrageenan matrices. AAPS PharmSciTech 5, 25 (2004). https://doi.org/10.1208/pt050225

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt050225

Keywords

Search

Navigation